Black Diamond Therapeutics Inc
BDTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$111.74M
Close$
$6.37
226.5% upside
Current Fair Value
226.5% upsideUndervalued by 226.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $111.74 Million |
|---|---|
| Enterprise Value | $109.51 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.39 |
| Beta | 3.25 |
| Outstanding Shares | 57,367,283 |
Return
| Return on Equity | -44.29% |
|---|---|
| Return on Assets | -34.04% |
| Return on Invested Capital | -41.93% |
Valuation & Multiples
| P/E Ratio | -2.64 |
|---|---|
| PEG | 42.42 |
| Price to Sales | - |
| Price to Book Ratio | 1.95 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.39 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$7.14 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.8203▲ 139.73% |
|---|---|
| Total Calls | 56,200▼ 75.39% |
| Total Puts | 102,300▲ 5.90% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 67.29%▲ 0.72% |
|---|---|
| Total Invested | $82.03M▼ 10.86% |
| Investors Holding | 108▼ 2.00% |
ESG Score
No data